Table 3.

Summary of treatments used for T-PLL

Therapeutic agent
No. of patients treated
Overall response, %
Alemtuzumab   22   64  
2-deoxycoformycin (2-DCF, pentostatin)   6   0  
2-chlorodeoxyadenosine (2-CDA)   10   33  
Fludarabine   5   40  
Arabinosyl guanine   12   58  
Regimens with alkylating agents and fludarabine   11   46  
Regimens with alkylating agents and anthracycline
 		 12
 		 50
 
Therapeutic agent
No. of patients treated
Overall response, %
Alemtuzumab   22   64  
2-deoxycoformycin (2-DCF, pentostatin)   6   0  
2-chlorodeoxyadenosine (2-CDA)   10   33  
Fludarabine   5   40  
Arabinosyl guanine   12   58  
Regimens with alkylating agents and fludarabine   11   46  
Regimens with alkylating agents and anthracycline
 		 12
 		 50
 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal